A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should.

Slides:



Advertisements
Similar presentations
Among Asian Americans and Pacific Islanders
Advertisements

1 Cover page Let’s Review Changes in CDC Recommendations in 2011 Carolee’s Corner January 2012 MPCA
Meningococcemia: Epidemiology & Prevention Baylor College of Medicine Med-Peds Continuity Clinic Anoop Agrawal, M.D.
Hepatitis B Virus and Cancer Everett Schlam, MD 9/22/2011.
The Essentials of Perinatal Hepatitis B Prevention A Training Series for Coordinators and Case Managers.
Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
IMCI Dr. Bulemela Janeth (Mmed. Pead) 1IMCI for athens.
Development of Sci B Vac: a Pre-S 1 /Pre-S 2 /S Hepatitis B Vaccine Daniel Shouval Liver Unit Hadassah and Hebrew University JerusalemIsrael.
Adult Immunization 2010 Hepatitis B Vaccine Segment
HEPATITIS B MARKERS AND VACCINE
Hepatitis B Vaccines Susan Goldstein, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Perinatal Hepatitis B Lynn Pollock, RN, MSN New York State Department of Health
MEASLES VACCINATION 2015 Update Susan Reeser RN, BSN (406)
HEPATITIS A VIRUS Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.
Hepatitis B Basics. ???? “A silent killer” 10X more common and 100X more infectious than HIV The cause of up to 80% of liver cancer cases worldwide.
Immunisation Update. Changes to the immunisation schedule Contraindications and precautions to vaccination Epidemic update.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.
HBV Jeopardy! Statistics Transmission Prevention DiagnosisTreatmentGrab Bag
1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.
Hepatitis B Virus 28.
Viral Hepatitis - Historical Perspective A “Infectious” “Serum” Viral hepatitis Entericallytransmitted Parenterallytransmitted F, G, ? other E NANB BD.
Overview National Hepatitis B Data
Connecticut Immunization Hot Topics Teleconference Series September 2011 NANCY FENLON, RN, MS CDC National Center for Immunization and Respiratory Diseases.
Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.
Updated ACIP Recommendations for Using Hepatitis A Vaccine for Postexposure and International Travel Management Miriam J. Alter, Ph.D., MPH Infectious.
Viral Hepatitis Program Perinatal Case Management Amy E. Warner, M.P.H. Colorado Department of Public Health.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
What is hepatitis B? Hepatitis B is a virus that infects the liver.
Immunization By DR BAHA M HASSEN. 4month male baby with good health and normal development had in duration,painful and red swelling at site of previous.
21/2/ Viral Hepatitis B (HBV) Associate Professor Family and Community Medicine Department King Saud University.
EPI VACCINES. BCG ( Bacille Calmette- Guerin)  Protects infants against TB  In powder form with diluents  Must be discarded after 6 hrs. or at the.
21th VHPB Meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 Impact of HBV S-gene mutants.
Carly Hanson, Jody Starr, Jessica Linn, and Lisa Harter.
Efficacy of immunization among HIV infected adults: An Observation R Bansal, N Gupta Crosslay AIDS & Wellness Centre Pushpanjali Crosslay Hospital Vaishali.
1 Vaccines Contraindications. Contraindications to any routine active immunization procedure An acute febrile illness, malaise, cough, diarrhea, or other.
“What Family Physicians Need to Know” Dr. Marie Andrades Senior Instructor Family Medicine ADULT IMMUNIZATION.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Hepatitis B and Hepatitis B Vaccine
Isolated Hepatitis B Core Antibody
SAMANTHA ALLEN PHARMACY STUDENT PHARMD CANDIDATE 2012 SEPTEMBER 27, 2011 Hepatitis B Vaccination in Cirrhotic Liver Transplant Candidates.
Medical errors put infants at risk for chronic hepatitis B virus infection – six case reports Debra Blog, MD, MPH, Elizabeth Herlihy, RN, BSN, MS,
What is a vaccine? A vaccine is a medicine that's given to help prevent a disease. Vaccines help the body produce antibodies. These antibodies protect.
Diabetes and Obesity Journal Club Carina Signori Endocrinology Fellow
1 Influenza Vaccination 2016 Cluster: Communicable Disease, NDoH.
Vaccination Recommendations Sepehr Khashaei Assistant Professor of Internal Medicine.
Prevention of Perinatal and Childhood Hepatitis B Virus Infections Background on Where We’ve Been Lisa Jacques-Carroll, MSW Immunization Services Division,
Tips and Tricks: Child/Adolescent Immunization Schedule Candice Robinson, MD, MPH Medical officer March 16, 2016 National Center for Immunization & Respiratory.
Adult Immunizations August 23, 2004 Vinod Kurup, MD
Guidelines for Vaccinating Dialysis Patients BY: DR. JONAIDI ASSOCIATE PROF. OF INFECTIOUS DISEASES.
PERINATAL HEPATITIS B PREVENTION Kristin Gerard, MPH Epidemiologist, Immunization Program Connecticut Department of Public Health.
What’s Up With All Those Other Vaccines?
Pneumococcal Vaccination Small group cases:Facilitator’s Guide
Pneumococcal vaccination in adults: PCV13?.. PPSV23?.. both??
Presenter ITODO EWAOCHE
© I.M.Quizitor Pediatrics Date.
Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP
Study of hepatitis B vaccination to students whom firstly demonstrated anti-HBs negative or titer < 10 mIU/ml 1Prapan Jutavijittum*,
The vaccination of hepatitis B in healthy adults: effect of age and sex, 2 protocols of revaccination for non-responders Jacques Choucair MD Infectious.
Fractional IPV (fIPV) eligibility
World Health Organization
RISK R isk of Perinatal and Early Childhood Infection
Hepatitis Primary Care: Clinics in Office Practice
World Health Organization
World Health Organization
In Canada, the rates of hepatitis B infection are low (less than 0.5%).  During the past four decades most Canadian immigrants have come from countries.
World Health Organization
World Health Organization
Presentation transcript:

A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should be done? u A. start again from zero. u B. you offer a third dose of hepatitis B vaccine u C. you first control the anti-HBs and if > 10 IU/L, u D. you tell her she is protected

A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should be done? u A. start again from zero. u B. you offer a third dose of hepatitis B vaccine u C. you first check the anti-HBs and if > 10 IU/L, u D. you tell her she is protected

Delayed and Incorrect Doses of Hepatitis B Vaccine  If vaccination series is interrupted – no need to restart series – second dose missed: give missing dose and continue series – third dose missed: complete series  If an incorrect (i.e., low) dose of vaccine is given, dose should be repeated

A 45 year old nurse is going to work in an orphanage in an Eastern European country. She received 3 doses of hepatitis B vaccine in She can remember she was tested and her anti-HBs was 1124 mIU/ml. What do you recommend? u A. tell her she is protected for life. u B. tell her she should start vaccination from zero again u C. offer her one additional dose and measure the anti- HBs one month later again. u D. test for anti-HBs before any further intervention.

A 45 year old nurse is going to work in an orphanage in an Eastern European country. She received 3 doses of hepatitis B vaccine in She can remember she was tested and her anti-HBs was 1124 mIU/ml. What do you recommend? u A. tell her she is protected for life. u B. tell her she should start vaccination from zero again u C. offer her one additional dose and measure the anti- HBs one month later again. u D. test for anti-HBs before any further intervention.

As part of your adolescent immunization programme you are considering post-vaccination serologic testing. Is this indicated? u A. yes, for all ado ’s u B. no, for no one. u C. yes, for some adolescents.

As part of your adolescent immunization programme you are considering post-vaccination serologic testing. Is this indicated? u A. yes, for all ado ’s u B. no, for no one. u C. yes, for some adolescents.

Post-Vaccination Testing Vaccine highly immunogenic >95% seroconversion after 3-dose series Almost all vaccinated persons protected Post-vaccination testing NOT indicated after routine immunization

A 33 year old HCW comes in your practice for anti-HBs control 8 years after he got a complete vaccination schedule. And he wants to be tested. What shall you do? u A. he is protected for life u B. he should start vaccination from zero again u C. offer him one additional dose and measure the anti-HBs one month later again. u D. try to check whether anti-HBs data are available from the past u E. tell him he is not protected u F. check his anti-HBS as requested

A 33 year old HCW comes in your practice for anti-HBs control 8 years after he got a complete vaccination schedule. And he wants to be tested. What shall you do? u A. he is protected for life u B. he should start vaccination from zero again u C. offer him one additional dose and measure the anti-HBs one month later again. u D. try to check whether anti-HBs data are available from the past u E. tell him he is not protected u F. check his anti-HBS as requested

Long-Term Protection with Hepatitis B Vaccine  Vaccine provides long-term protection  Immunity persists despite loss of anti-HBs  documented protection up to 15 years – lifelong protection likely – continued follow-up needed to determine duration of protection Booster doses of hepatitis B vaccine NOT currently recommended

Mechanism of Long-Term Protection with Hepatitis B Vaccine Primary vaccination series Immune memory Anamnestic antibody response Rapid rise in anti-HBs Protection from infection Exposure to HBV

Serologic Response to Booster Dose of Hepatitis B Vaccine Primary series Booster dose (simulating natural infection) Source: Williams, CDC 2 weeks post-booster 4 weeks post-booster 1 year post-booster

Long-Term Protection with Hepatitis B Vaccine Among Vaccinated Infants and Children Country Anti-HBc Positive HBsAg Positive Anti-HBs >10 mIU/mln Years f/u China Hong Kong Taiwan Italy Gambia Italy % 1% 14% 12% 0 13% 1% 50% 74% 85% 67% 68% -- 68% % 0 0.4% 0 1% 0

Long-lasting protection: implications u scientific data do not support the need for routine booster vaccinations (ACIP, ACIP Canada, VHPB) u therefore, no booster recommendation : –for universal HB vaccination programmes (infants, children and adolescents) –for adults who are immunocompetent

Kane M et al. Lancet 2000; 355: Long-lasting protection: implications u European consensus group on hepatitis B immunity (October 1998, Florence): u no need for booster doses in immunocompetent individuals u HB booster vaccination to be considered for mmunocompromised individuals: »haemodialysis »chronic renal failure/liver disease »HIV positive »...

Long-lasting protection: benefits u Maintains immunity in the population u Reduces morbidity and mortality u Reduces transmission in the population u Protects against disease for longer  Reduces direct and indirect costs of booster vaccination programs

A mother brings her child for a second hepatitis B shot, and the child has a cold and fever of 38.0°C. What should you do? u A. give the shot as scheduled u B. send the child home, and tell the mother to bring the child back over one week. u C. give to shot and keep the child in your clinic for 24h. Observation.

A mother brings her child for a second hepatitis B shot, and the child has a cold and fever of 38.0°C. What should you do? u A. give the shot as scheduled u B. send the child home, and tell the mother to bring the child back over one week. u C. give to shot and keep the child in your clinic for 24h. Observation.

1. Minor illness with temp < Allergy or asthma 3. History of seizures 4. Family history of seizures 5. Treatment with antibiotics 6. Infection with HIV The Following are NOT Contraindications to Vaccination

7. Chronic diseases - such as chronic heart, lung, liver, kidney diseases 8. Stable neurologic conditions - such as cerebral palsey, Down’s syndrome 9. Premature infants 10. Jaundice at birth 11. Breast feeding 12. Pregnancy The Following are NOT Contraindications to Vaccination